株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

止血剤の世界市場予測 ~2023年:製品(トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン)、用途(婦人科手術、神経手術、心血管手術、再建手術)、形態(マトリックス材・ゲル、シート・パッド、パウダー、ゲル)、地域別

Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 352591
出版日 ページ情報 英文 141 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
止血剤の世界市場予測 ~2023年:製品(トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲン)、用途(婦人科手術、神経手術、心血管手術、再建手術)、形態(マトリックス材・ゲル、シート・パッド、パウダー、ゲル)、地域別 Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023
出版日: 2018年09月10日 ページ情報: 英文 141 Pages
概要

世界の止血剤市場は、2018年に22億7,000万米ドル、2023年に30億3,000万米ドルに達し、2018年から2023年のCAGR(複合年間成長率)で6.0%の成長が予測されています。

当レポートでは、世界の止血剤市場について調査し、市場の概要、製品・形態・用途・地域別の市場規模の推移と予測、市場動向、成長要因・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

FIGURE 10 HEMOSTATS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 止血剤市場の概要
  • アジア太平洋地域の止血剤市場
  • 止血剤市場:地域別
  • 地域分析

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 成長要因
    • 手術件数の増加
    • 規制機関による承認件数の増加
    • スポーツ傷害と脊椎疾患の発症率の上昇
    • 手術中の効果的な出血管理への取り組み
  • 市場機会
    • 病院および外科センターの増加
    • 新興市場
  • 阻害要因
    • 製品のリコール
    • 非常に断片化した市場構造
  • 課題
    • 専門家の不足
    • 高額なコスト

第6章 世界の止血剤市場:製品別

  • イントロダクション
  • トロンビン
  • 酸化再生セルロース
  • 併用止血剤
  • ゼラチン
  • コラーゲン

第7章 世界の止血剤市場:形態別

  • イントロダクション
  • ゲル・マトリックス材
  • シート・パッド
  • スポンジ
  • パウダー

第8章 世界の止血剤市場:用途別

  • イントロダクション
  • 整形外科手術
  • 一般手術
  • 神経手術
  • 心血管手術
  • 再建手術
  • 婦人科手術
  • その他

第9章 世界の止血剤市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 市場概要
  • 市場シェアの分析
  • 競合情勢
    • 新製品の承認と上市
    • 買収
    • 合意
    • 事業拡大

第11章 企業プロファイル

  • C. R. BARD
  • B.BRAUN
  • BAXTER
  • INTEGRA LIFESCIENCES
  • MARINE POLYMER TECHNOLOGIES
  • PFIZER
  • GELITA MEDICAL GMBH
  • Z-MEDICA, LLC
  • ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON)
  • TELEFLEX INCORPORATED

第12章 付録

表リスト

図表

LIST OF TABLES

  • TABLE 1: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 2: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 3: THROMBIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: THROMBIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 5: OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 7: COMBINATION HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: COMBINATION HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 9: GELATIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: GELATIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 11: COLLAGEN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: COLLAGEN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 13: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 14: MATRIX & GEL HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: SHEET & PAD HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: SPONGE HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: POWDER HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 19: HEMOSTATS MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: HEMOSTATS MARKET FOR GENERAL SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: HEMOSTATS MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: HEMOSTATS MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: HEMOSTATS MARKET FOR RECONSTRUCTIVE SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: COUNTRIES WITH THE HIGHEST C-SECTION RATE (2015)
  • TABLE 25: HEMOSTATS MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: HEMOSTATS MARKET FOR OTHER SURGERIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 30: NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 31: NORTH AMERICA: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 32: NORTH AMERICA: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 33: US: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 34: US: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 35: CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 36: CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 37: EUROPE: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 39: EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 40: EUROPE: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 41: EUROPE: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 42: GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 43: GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 ( THOUSAND UNITS)
  • TABLE 44: UK: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 45: UK: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 46: FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 47: FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 48: ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 49: ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 50: SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 51: SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 52: RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 53: RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 54: SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 55: SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 56: BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 57: BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 58: ROE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 59: ROE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 60: ASIA PACIFIC: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 63: ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 65: CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 66: CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 67: JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 68: JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 69: INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 70: INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 71: AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 72: AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 73: SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 74: SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 75: NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 76: NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 77: SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 78: SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 79: INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 80: INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 81: MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 82: MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 83: ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 84: ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 85: LATIN AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 86: LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 87: LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 88: LATIN AMERICA: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 89: LATIN AMERICA: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 90: BRAZIL: KEY MACROINDICATORS FOR THE HEMOSTATS MARKET
  • TABLE 91: BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 92: BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 93: MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 94: MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 95: REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 96: REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 97: MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 98: MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 99: MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS)
  • TABLE 100: MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 101: MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: HEMOSTATS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: HEMOSTATS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: HEMOSTATS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: HEMOSTATS MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: INCREASING NUMBER OF SURGICAL PROCEDURES IS EXPECTED TO DRIVE MARKET GROWTH
  • FIGURE 11: MATRIX AND GEL HEMOSTATS ARE EXPECTED TO COMMAND THE LARGEST MARKET SHARE IN 2018
  • FIGURE 12: NORTH AMERICA IS EXPECTED TO HOLD THE LARGEST SHARE OF THE HEMOSTATS MARKET IN 2018
  • FIGURE 13: INDIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: HEMOSTATS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: COMBINATION HEMOSTATS TO WITNESS THE HIGHEST GROWTH IN THE HEMOSTATS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: SPONGE HEMOSTATS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: RECONSTRUCTIVE SURGERY TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE GLOBAL HEMOSTATS MARKET IN 2018
  • FIGURE 19: NORTH AMERICA: HEMOSTATS MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS OF MAJOR PLAYERS FROM 2015 TO 2018
  • FIGURE 21: HEMOSTATS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017
  • FIGURE 22: C. R. BARD: COMPANY SNAPSHOT (2016)
  • FIGURE 23: B. BRAUN: COMPANY SNAPSHOT (2017)
  • FIGURE 24: BAXTER: COMPANY SNAPSHOT (2017)
  • FIGURE 25: INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2017)
  • FIGURE 26: PFIZER: COMPANY SNAPSHOT (2017)
  • FIGURE 27: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 28: TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2017)
目次
Product Code: MD 4093

"The global hemostats market is projected to grow at a CAGR of 6.0% during the forecast period."

The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.

"In 2018, the thrombin-based hemostats are expected to dominate the hemostats market."

On the basis of product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. In 2018, the thrombin-based hemostats segment is estimated to hold the largest share of the market. The large share of this segment is attributed to the wide range of advantages associated with the use of thrombin-based hemostats.

"The sponge hemostats segment is estimated to grow at the highest rate in the next five years."

Based on formulation, the hemostats market has been segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. The sponge hemostats segment is expected to witness the highest growth during the forecast period. The positive growth rate of this segment is attributed to the growing acceptance of these formulations by end users.

"Asia Pacific is estimated to grow at the highest CAGR during the study period."

Geographically, the hemostats market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the highest rate during the forecast period. The improving healthcare infrastructure, growing medical tourism, increasing number of elderly people in the region, and the implementation of favorable government initiatives in several Asian countries, are driving the growth of this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1-70%, Tier 2-30%
  • By Designation: C level-62%, Director level-21%, Others-17%
  • By Region: North America-50%, Europe-20%, Asia Pacific-30%

The key players in the hemostats market include: CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

Research Coverage:

The report analyses the hemostats market by product, application, formulation, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the hemostats market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one, or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the hemostats market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the hemostats market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the hemostats market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various hemostats products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hemostats market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. DATA TRIANGULATION METHODOLOGY
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HEMOSTATS: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION (2018)
  • 4.3. HEMOSTATS MARKET, BY REGION (2018)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE HEMOSTATS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
  • 5.3. DRIVERS
    • 5.3.1. INCREASING NUMBER OF SURGICAL PROCEDURES
    • 5.3.2. GROWING NUMBER OF REGULATORY APPROVALS
    • 5.3.3. INCREASING INCIDENCE OF SPORTS-RELATED INJURIES AND SPINAL AILMENTS
    • 5.3.4. RISING FOCUS ON EFFECTIVE BLOOD LOSS MANAGEMENT IN PATIENTS DURING SURGERIES
  • 5.4. MARKET OPPORTUNITIES
    • 5.4.1. GROWTH IN THE NUMBER OF HOSPITALS & SURGICAL CENTERS
    • 5.4.2. EMERGING MARKETS
  • 5.5. MARKET RESTRAINTS
    • 5.5.1. PRODUCT RECALLS
    • 5.5.2. HIGHLY CONSOLIDATED MARKET
  • 5.6. MARKET CHALLENGES
    • 5.6.1. DEARTH OF SKILLED PERSONNEL
    • 5.6.2. HIGH COST OF HEMOSTATS

6. HEMOSTATS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. THROMBIN-BASED HEMOSTATS
  • 6.3. OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS
  • 6.4. COMBINATION HEMOSTATS
  • 6.5. GELATIN-BASED HEMOSTATS
  • 6.6. COLLAGEN-BASED HEMOSTATS

7. HEMOSTATS MARKET, BY FORMULATION

  • 7.1. INTRODUCTION
  • 7.2. MATRIX & GEL HEMOSTATS
  • 7.3. SHEET & PAD HEMOSTATS
  • 7.4. SPONGE HEMOSTATS
  • 7.5. POWDER HEMOSTATS

8. HEMOSTATS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. ORTHOPEDIC SURGERY
  • 8.3. GENERAL SURGERY
  • 8.4. NEUROLOGICAL SURGERY
  • 8.5. CARDIOVASCULAR SURGERY
  • 8.6. RECONSTRUCTIVE SURGERY
  • 8.7. GYNECOLOGICAL SURGERY
  • 8.8. OTHER SURGERIES

9. HEMOSTATS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. RUSSIA
    • 9.3.7. SWITZERLAND
    • 9.3.8. BELGIUM
    • 9.3.9. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. AUSTRALIA
    • 9.4.5. SINGAPORE
    • 9.4.6. NEW ZEALAND
    • 9.4.7. SOUTH KOREA
    • 9.4.8. INDONESIA
    • 9.4.9. MALAYSIA
    • 9.4.10. REST OF ASIA PACIFIC
  • 9.5. LATIN AMERICA
    • 9.5.1. BRAZIL
    • 9.5.2. MEXICO
    • 9.5.3. REST OF LATIN AMERICA
  • 9.6. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. ACQUISITIONS
    • 10.3.3. AGREEMENTS
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. C. R. BARD
  • 11.2. B.BRAUN
  • 11.3. BAXTER
  • 11.4. INTEGRA LIFESCIENCES
  • 11.5. MARINE POLYMER TECHNOLOGIES
  • 11.6. PFIZER
  • 11.7. GELITA MEDICAL GMBH
  • 11.8. Z-MEDICA, LLC
  • 11.9. ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON)
  • 11.10. TELEFLEX INCORPORATED

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS
Back to Top